Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Transportation ETF (XTN) belongs to the US Industrials segment. GMO Domestic Resilience ETF (DRES) is part of the US Multi-Factor segment. Both ETFs have the same top 3 sector exposures: and Industrials. XTN is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.25% for DRES. XTN is down -3.82% year-to-date (YTD) with +$123M in YTD flows. DRES performs better with 10.04% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of XTN and DRES below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XTN DRES | -12.14%-5.46% | -6.38%+6.16% | -3.82%+10.04% | +18.80%n/a | +26.33%n/a | +4.29%n/a |
| Flows | XTN DRES | +$5M+$872K | +$123M+$4M | +$123M+$3M | +$73M- | -$3M- | -$269M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XTN DRES | +29.39%+19.38% | +32.15%n/a | +25.45%n/a | +26.21%n/a |
| Max drawdown | XTN DRES | -17.11%-6.43% | -18.25%n/a | -33.63%n/a | -35.03%n/a |
| Max drawdown duration | XTN DRES | 32d9d | 46dn/a | 380dn/a | 1519dn/a |
XTN | DRES | |
Last sale 3/13/2026 at 1:30 PM | $87.77 | $27.38 |
| Previous close 03/12/2026 | $87.79 | $27.47 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XTN | DRES | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XTN | DRES | |
|---|---|---|
| Last price | $87.77 | $27.38 |
| 1D performance | -0.02% | -0.33% |
| AuM | $256.48 M | $35.44 M |
| E/R | 0.35% | 0.25% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
